Arecor Therapeutics announced plans to cease operations within its subsidiary Tetris Pharma during 2025 on Friday, adding ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

(Sharecast News) - Arecor Therapeutics announced plans to cease operations within its subsidiary Tetris Pharma during 2025 on Friday, adding that it had mutually agreed with Xeris BioPharma to ...

CAMBRIDGE, UK - Arecor Therapeutics plc (AIM: LON:AREC), a biopharmaceutical company, today announced the planned orderly cessation of operations at its subsidiary Tetris Pharma during 2025. The move ...

CAMBRIDGE, UK - Arecor Therapeutics plc (AIM: LON:AREC), a biopharmaceutical company, today announced the planned orderly cessation of operations at its subsidiary Tetris Pharma during 2025.

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience. To access our Live RNS you must confirm you are a private ...

Shares in Cambridge biopharma company Arecor Therapeutics hit a 52-week low at 54.75p on Friday before recovering to close at ...

Arecor Therapeutics has signed an exclusive licensing agreement for AT351, its ready-to-dilute (RTD) liquid drug product, ...

Read on further for ongoing weekly news from studies across the globe. Arecor Therapeutics’ (PDF) ultra-concentrated, ultra-rapid acting insulin candidate AT278 has demonstrated superiority in a ...